Clinical Trial Update: Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating conditioning regimens with busulfan-based chemotherapy before donor hematopoietic cell transplant in younger patients with juvenile mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Myelomonocytic Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Melphalan (Melphalan)
• busulfan and fludarabine phosphate (busulfan; fludarabine phosphate)

Snippet

Sponsor: Children's Oncology Group | Conditions: Juvenile Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-12-05